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Dosimetric considerations for in vitro testing -Example of calculations
The following example shows the step-by-step calculations performed to arrive at the number of hours of PEPs inhalation that match the delivered-to-cell doses (e.g., 0.5 µg/ml) used for the two cell lines (SAECs, THP-1) in the study.
1. Choose the administered dose of interest used in the experiment to determine the corresponding inhalation exposure to PEPs. For this example, we chose the administered dose of 0.5 µg/ml.
Calculate the mass administered (µg) per well in a 96-well plate
Mass administered-to-cell in one well (µg) = administered dose * administered volume Mass administered-to-cell in one well (µg) = (0.5 µg/ml) * (0.1 ml) = 0.05 µg
Converting the administered mass to delivered to cell dose as a function of the in vitro exposure time (t = 24 hrs) using the in vitro dosimetric methodology (Cohen et al. 2014):
The fraction of administered particle mass that is deposited on the cells in a standard 96-well plate as a function of in vitro exposure time (f D ) is calculated. For a 24-hour in vitro exposure, the f D was found to be 1.0 for particles suspended in SAGM (SAECs) and 0.518 for particles suspended in RPMI/10%FBS (THP-1). Therefore, the delivered to cell in vitro mass is as follows: Untreated 5 µg/mL 10 µg/mL 20 µg/mL 40 µg/mL 5 µg/mL 10 µg/mL 20 µg/mL 40 µg/mL 5 µg/mL 10 µg/mL 20 µg/mL 40 µg/mL H 2 O 2
